First controlled trial of sibutramine vs. topiramate in bipolar disorder Carlat Reports

First controlled trial of sibutramine vs. topiramate in bipolar disorder

The Carlat Psychiatry Report, Volume 5, Number 9, September 2007
https://www.thecarlatreport.com/newsletter-issue/tcprv5n9/

From The Carlat Psychiatry Report, September 2007, Complex Psychopharmacology

Issue Links: Learning Objectives | Editorial Information

Ronald Pies, MD

It was a sorely needed study: compare sibutramine (Meridia) with topiramate (Topamax) in patients with psychotropicassociated weight gain. Sibutramine is generally considered one of the most effective weight loss agents.

You can't view details of this content, please login or buy subscription here

Ronald Pies, MD

Professor of Psychiatry, SUNY Upstate Medical University, Syracuse Clinical Professor of Psychiatry, Tufts Univeristy School of Medicine, Boston

Dr. Pies has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.